Back to Search Start Over

Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database

Authors :
Danlei Song
Yongjian Wei
Yuping Hu
Xia Chen
Ya Zheng
Min Liu
Yuping Wang
Yongning Zhou
Source :
Discover Oncology, Vol 12, Iss 1, Pp 1-22 (2021)
Publication Year :
2021
Publisher :
Springer, 2021.

Abstract

Abstract Background Esophageal squamous cell carcinoma (ESCC) is the most common histological type of esophageal cancer in the world with high incidence rate and poor prognosis. Infiltrated immune and stromal cells are vital components of tumor microenvironment (TME) and have a significant impact on the progression of ESCC. The competitive endogenous RNA (ceRNA) hypothesis has been proved important in the molecular biological mechanisms of tumor development. However, there are few studies on the relationship between ceRNA and ESCC TME. Methods The proportion of tumor-infiltrating immune cells and the amount of stromal and immune cells in ESCC cases were calculated from The Cancer Genome Atlas database using the CIBERSORT and ESTIMATE calculation methods. After stratified identification of differentially expressed genes, WGCNA and miRNA prediction system were applied to construct ceRNA network. Finally, PPI network and survival analysis were selected to discriminate prognostic signature. And the results were verified in two independent groups from Gene Expression Omnibus and Lanzhou, China. Results We found that high Stromal and ESTIMATE scores were significantly associated with poor overall survival. Three TME-related key prognostic genes were screened, namely, LCP2, CD86, SLA. And the expression of them was significantly correlated with infiltrated immunocytes. It is also found that ESTIMATE Score and the expression of CD86 were both related to TNM system of ESCC. Conclusions We identified three novel TME-related prognostic markers and their lncRNA-miRNA-mRNA pathway in ESCC patients, which may provide new strategies for the targeted therapy.

Details

Language :
English
ISSN :
27306011
Volume :
12
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Discover Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.0a5c9a90fba406184f94a9552d77005
Document Type :
article
Full Text :
https://doi.org/10.1007/s12672-021-00442-5